Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha
about
The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific TreatmentsAlcohol, insulin resistance and the liver-brain axisTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseAn intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseSelective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapyHepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicityChronic pain and hepatitis C virus infection in opioid dependent injection drug usersThe liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha.Frequency of depression among patients with neurocysticercosis.Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetineMetabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesNeuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.Human sickness behavior: Ultimate and proximate explanations.Methamphetamine causes persistent immune dysregulation: a cross-species, translational report.Concomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons.Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats.Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.Immune aging, dysmetabolism, and inflammation in neurological diseases.Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in ChinaTriangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedPain-related anxiety mediates the relationship between depressive symptoms and pain interference in veterans with hepatitis C.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.Cerebral Response to Peripheral Challenge with a Viral Mimetic.Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.Impact of Depression and Inflammation on the Progression of HIV Disease.The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.A critical review of human endotoxin administration as an experimental paradigm of depression.Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.Preliminary indications of the effect of a brief yoga intervention on markers of inflammation and DNA methylation in chronically stressed women.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.Liver-brain inflammation axis.Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions.Evidence for a dysregulated immune system in the etiology of psychiatric disorders.Hepatitis regulation by the inflammasome signaling pathway.
P2860
Q26783012-2860C7C5-911E-48F4-B248-D36B6EF88BD2Q26991846-4A56C13D-5CD6-47E5-8460-1F13A27A2B61Q27021700-E20A9999-42C5-4D5F-B9CA-72F692F5EE6AQ27491346-387F075C-AA19-45DE-A746-905EDCD59EB8Q28259585-CF226A0F-8F5F-4D2C-8A7D-3963FD817591Q28728766-89047535-5249-4DB9-8942-DF07AEF779ABQ33705274-61C34EA1-AE6D-4079-8722-38CAC63C893AQ33872397-3A048FAC-5EE5-47BA-B0CA-1BA89A096FA1Q33962438-CD8763F3-95EE-408C-AC11-6B8AD4B4B7FDQ34026599-F7D71619-F08E-4252-B0A5-1297084408EDQ34106781-954ABA3F-1058-4B6D-92C1-C8494C6FB4B7Q34137925-58FDDE83-F87E-4BBC-AAA0-A367C754057DQ34256005-C12F4BE2-1CDC-439F-A3C3-E1D080CB8987Q34288447-CCF587D4-C02A-4FE2-BCE2-59DFB3495D76Q34369407-F06DCEAA-351C-4D9E-BBEC-05E4049EF0EFQ34460763-6A44C0DA-90CD-4A88-8970-0B28E81CB0C7Q34843459-1395EF5A-01F2-40FE-80AE-D20FF13195EEQ35082408-1157407B-7F9A-45DB-A4D5-6C603A8CAAF3Q35118685-D3707591-7DAF-40C8-BED0-152E451E7565Q35128609-ABD11070-CECB-4E6E-ADBA-01F8B874490AQ35380856-40690FEC-ED35-4652-943E-B3342F08615FQ35619107-E3CD8194-1FB0-4601-ACF3-3E4037C8E165Q35677347-6FB957D0-3433-49A0-B95A-0084CC220B58Q35875495-B63D2C2B-ACB3-447E-A4C5-28776A086B83Q35885462-836DEC0D-3058-4B63-9D30-A451E67AEA69Q35997884-BB32B100-7F07-4F0B-B68D-490FD9E54B72Q36240463-9E28AEB6-CF73-491B-9CD7-637F549DE97CQ36381738-B14F13EC-4D31-4D7E-971A-C1B6CCF63D42Q36642774-18984638-CB37-4348-8AA3-C9C019FA82E7Q37052393-FC31E964-9E73-4B96-8042-585E0A0B31A5Q37138606-C1455573-8147-4C18-84CE-D58C84708296Q37335385-D2BF7544-D172-4B7C-B578-A80564313E6AQ37481759-1AAFA6E4-BFA9-4CFA-B4F3-9111CD6B1853Q37602608-F242F669-7F11-4C53-B4EB-14D7BC808419Q37622669-6952F29D-C0E3-4F8A-979E-3B12FA7AB56DQ37668003-EC667D54-3EEB-4748-BBE8-6F16AB7252F4Q37922460-C0B9AF13-5DC6-470A-9492-5416603CC7E3Q38100813-8CED4C8A-65B0-4469-A8ED-07897DFDA92DQ38104284-924D16D3-4706-4887-91DE-F07003E26F25Q38423384-579B7186-3E27-42D4-8915-A918E7CD644F
P2860
Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Depressive symptoms in patient ...... nd tumor necrosis factor-alpha
@ast
Depressive symptoms in patient ...... nd tumor necrosis factor-alpha
@en
type
label
Depressive symptoms in patient ...... nd tumor necrosis factor-alpha
@ast
Depressive symptoms in patient ...... nd tumor necrosis factor-alpha
@en
prefLabel
Depressive symptoms in patient ...... nd tumor necrosis factor-alpha
@ast
Depressive symptoms in patient ...... nd tumor necrosis factor-alpha
@en
P2093
P2860
P1433
P1476
Depressive symptoms in patient ...... nd tumor necrosis factor-alpha
@en
P2093
David J Hinrichs
Marilyn Huckans
Peter Hauser
Samantha Ruimy
P2860
P304
P356
10.1016/J.NEULET.2007.11.001
P407
P577
2007-11-06T00:00:00Z